Bringing the fundamentals into focus…
Back to NewAmsterdam Pharma Company N.V.
How NewAmsterdam Pharma Company N.V. stacks up
NAMS · against 372 other Healthcare companies of similar size
Profitability
3/ 100
Near the bottom of its peers.
Ranked #361 of 373 · scores higher than 2% of peers
Bars: peers in each 10-point band of the profitability score30 peers with a profitability score of 0–9, including NAMS · Click a bar to see the companies
Why profitability scores 3?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 97% of peers. Operating margin: -3432.2% vs peer median 7.1%
- a lower return on invested capital: weaker than 93% of peers. Return on invested capital: -93.2% vs peer median 4.7%
- a lower return on assets: weaker than 89% of peers. Return on assets: -36.7% vs peer median 1.7%
Metric by metric
Position: dot = NAMS, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NAMS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 351 reported | -93.2% | 6.3% | 7% | 33% | |
| Operating marginHigher is better · 343 reported | -3432.2% | 8.6% | 3% | 33% | |
| Return on assetsHigher is better · 358 reported | -36.7% | 2.1% | 9% | 33% | |
| Return on equityHigher is better · 345 reported | -36.8% | 5.2% | 19% | Context only | |
| Gross marginHigher is better · 386 reported | 100.0% | 48.5% | 97% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around NAMS| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 361 | 1.7B USD | 3 | 23 | |
| 361 | 3.1B USD | 3 | 27 | |
| 361 | 1.2B USD | 3 | 3 | |
| 361 | 2.4B USD | 3 | 27 | |
| 361 | 2.3B USD | 3 | 26 | |
| 361 | 2.0B USD | 3 | 24 | |
| 367 | 1.7B USD | 2 | 30 | |
| 367 | 1.8B USD | 2 | 23 | |
| 369 | 1.8B USD | 1 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score